These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 1479730

  • 1. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin.
    Suzuki Y, Ogura Y, Otsubo O, Mimura N, Takaku F, Maeda T.
    Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1019-23. PubMed ID: 1479730
    [Abstract] [Full Text] [Related]

  • 2. [The treatment of anemia of hemodialysis patients using recombinant human erythropoietin: comparison between intravenous and subcutaneous administration].
    Zehnder C, Blumberg A.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):217-20. PubMed ID: 2309110
    [Abstract] [Full Text] [Related]

  • 3. Human recombinant erythropoietin treatment in transfusion dependent anemic patients on maintenance hemodialysis.
    Zehnder C, Blumberg A.
    Clin Nephrol; 1989 Feb 17; 31(2):55-9. PubMed ID: 2920469
    [Abstract] [Full Text] [Related]

  • 4. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP, Abels RI, McNeill MV, Sullivan DJ.
    Arch Intern Med; 1993 Dec 13; 153(23):2669-75. PubMed ID: 8250662
    [Abstract] [Full Text] [Related]

  • 5. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G.
    Pediatr Med Chir; 1991 Dec 13; 13(5):475-7. PubMed ID: 1788107
    [Abstract] [Full Text] [Related]

  • 6. [Numerical and functional alterations in T and B lymphocyte subpopulations in CAPD patients treated with recombinant human erythropoietin].
    Tanabe R.
    Nihon Jinzo Gakkai Shi; 1994 Oct 13; 36(10):1159-68. PubMed ID: 7815748
    [Abstract] [Full Text] [Related]

  • 7. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
    Lebel M, Kingma I, Grose JH, Langlois S.
    Am J Hypertens; 1995 Jun 13; 8(6):545-51. PubMed ID: 7662237
    [Abstract] [Full Text] [Related]

  • 8. Development of a comprehensive red blood cell enzymopathy laboratory in Thailand: the study of normal activity in eight erythroenzymes in Thais.
    Tachavanich K, Viprakasit V, Pung-Amritt P, Veerakul G, Chansing K, Tanphaichitr VS.
    Southeast Asian J Trop Med Public Health; 2009 Mar 13; 40(2):317-26. PubMed ID: 19323017
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin].
    Prata MM, de Sousa FT, Barbas JV, da Costa AM, Vinhas J, Moreira P, Abrantes C, Lopes MC.
    Acta Med Port; 1990 Mar 13; 3(3):149-53. PubMed ID: 2220424
    [Abstract] [Full Text] [Related]

  • 11. Monitoring considerations in recombinant human erythropoietin therapy.
    Ogden DA.
    Semin Nephrol; 1989 Mar 13; 9(1 Suppl 2):12-5. PubMed ID: 2669080
    [Abstract] [Full Text] [Related]

  • 12. [The effects of r-HuEPO on platelet function and coagulation factors in hemodialysis patients].
    Kinugasa E, Nabeshima K, Niikura K, Kawabe S, Akizawa T, Kitaoka T, Koshikawa S.
    Nihon Jinzo Gakkai Shi; 1990 Oct 13; 32(10):1109-16. PubMed ID: 2287103
    [Abstract] [Full Text] [Related]

  • 13. [Hexokinase activity of erythrocytes in cancer patients].
    Sensini A, Braussi M, Spadoni M, Giacchi R.
    Quad Sclavo Diagn; 1981 Dec 13; 17(4):431-7. PubMed ID: 7347823
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989 Dec 13; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 15. Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system.
    Radermacher J, Koch KM.
    Clin Nephrol; 1995 Nov 13; 44 Suppl 1():S56-60. PubMed ID: 8608665
    [Abstract] [Full Text] [Related]

  • 16. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
    Delano BG.
    Am J Kidney Dis; 1989 Aug 13; 14(2 Suppl 1):14-8. PubMed ID: 2757025
    [Abstract] [Full Text] [Related]

  • 17. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
    Sánchez Casajús A, Barrau J, Gómez Alamillo C, Jaurrieta F.
    Sangre (Barc); 1990 Feb 13; 35(1):82-4. PubMed ID: 2333585
    [Abstract] [Full Text] [Related]

  • 18. Alterations in sex hormones and sexual function of patients with renal failure treated with recombinant human erythropoietin.
    Suzuki H, Murakami M, Ichihara A, Saruta T.
    Nihon Jinzo Gakkai Shi; 1992 Jan 13; 34(1):79-84. PubMed ID: 1593800
    [Abstract] [Full Text] [Related]

  • 19. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD, James KM, Levy JK, Browne JK, Miller A, Lobingier RT, Egrie JC.
    J Am Vet Med Assoc; 1998 Feb 15; 212(4):521-8. PubMed ID: 9491159
    [Abstract] [Full Text] [Related]

  • 20. Who should receive recombinant human erythropoietin?
    Van Stone JC.
    Semin Nephrol; 1989 Mar 15; 9(1 Suppl 2):3-7. PubMed ID: 2669084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.